NYSE - Nasdaq Real Time Price USD

Globus Medical, Inc. (GMED)

50.52 -0.92 (-1.79%)
As of 1:29 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David C. Paul Co-Founder & Executive Chairman 1.09M -- 1967
Mr. Daniel T. Scavilla President, CEO & Director 1.37M -- 1965
Mr. Keith W. Pfeil CFO & COO 675.89k -- 1980
Ms. Kelly G. Huller Esq. Senior VP, General Counsel & Secretary 543.24k 624.35k 1972
Mr. Brian J. Kearns Senior Vice President of Business Development & Investor Relations -- -- 1967

Globus Medical, Inc.

2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800 https://www.globusmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
5,000

Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Corporate Governance

Globus Medical, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 10; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024 - May 06, 2024
Globus Medical, Inc. Earnings Call

Related Tickers

ATEC Alphatec Holdings, Inc.
12.23
-4.00%
 
OFIX Orthofix Medical Inc.
13.04
-3.83%
 
MASI Masimo Corporation
133.91
-1.48%
 
FNA Paragon 28, Inc.
9.23
-4.27%
 
ZBH Zimmer Biomet Holdings, Inc.
119.54
-1.35%
 
NARI Inari Medical, Inc.
38.26
+0.21%
 
IRTC iRhythm Technologies, Inc.
112.47
-3.40%
 
TMCI Treace Medical Concepts, Inc.
10.27
-3.75%
 
CNMD CONMED Corporation
62.19
-11.20%
 
NVCR NovoCure Limited
12.21
-1.05%